Clinical Trial Update: Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests [Phase 3]

View source ↗

Summary

A Phase 3 trial to optimize adjuvant chemotherapy in young women with HR+/HER2- breast cancer using genomic tests; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNICANCER | Conditions: Early Breast Cancer, Premenopausal Breast Cancer | Phase 3 | Status: NOT_YET_RECRUITING